Cariprazine for schizophrenia
This study is completed in the United States. It is testing cariprazine for schizophrenia.
Multiple locations, including Dothan
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing cariprazine for schizophrenia.
Multiple locations, including DothanThis study is ongoing in Spain. It focuses on Bipolarity.
In SpainThis study is ongoing. It focuses on schizophrenia and currently lists study information in Germany.
In GermanyThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In MiamiThis study is ongoing. It focuses on bipolarity and currently lists study information in Norway, Sweden, Germany, Denmark, Spain, and Italy.
In NorwayThis study is completed. It focuses on bipolarity and currently lists study information in Turkey.
In IstanbulThis study has public registry information. It focuses on bipolarity and currently lists study information in the United Kingdom.
In CambridgeThis study is completed. It focuses on bipolarity and currently lists study information in Canada.
In HamiltonThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Salt Lake CityThis study is completed. It focuses on bipolarity and currently lists study information in Canada.
In OttawaThis study is completed. It focuses on bipolarity and currently lists study information in Pakistan.
In LahoreThis study is enrolling by invitation. It focuses on bipolarity and currently lists participation information in Turkey.
In KütahyaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.